好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Novel Neuroimaging Study for Painful Trigeminal Neuropathy
Pain
P4 - Poster Session 4 (5:00 PM-6:00 PM)
7-004

In this study, we examine the role of brain inflammation in painful trigeminal neuropathy (PTN). 

Painful trigeminal neuropathy is a chronic facial pain typically caused by trigeminal nerve injuries. It is frequently refractory to medication management, and our understanding of pathophysiological mechanisms is limited. In this study, we examine the role of brain inflammation in PTN

Eleven patients with PTN, evaluated by a neurologist (HTC), completed a positron emission tomography-magnetic resonance imaging (PET/MR) scan with the radioligand [11C]PBR28, which binds to the 18 kDa Translocator protein (TSPO), a marker of brain inflammation. [11C]PBR28 PET maps (standard uptake value ratio; SUVR) were spatially normalized to the Montreal Neurological Institute space and smoothed (Full width at half maximum = 8 mm). For each participant, the mean [11C]PBR28 signal value was extracted from three regions-of-interest (thalamus, insula, and postcentral gyrus, identified using the Harvard-Oxford Cortical and Subcortical Structural Atlases) and compared across hemispheres based on pain laterality (i.e., ipsilateral vs contralateral to the primary side of pain) using a paired t-test, separately for each region. 

Of the three regions explored, the thalamus displayed a statistically significant hemispheric difference, with the contralateral side demonstrating a higher [11C]PBR28 signal compared to the ipsilateral side (p=0.006). There was no significant hemispheric difference for insula (p=0.42) and postcentral gyrus (p=0.92). On an individual level, the majority of participants (82%) show increased contralateral thalamic signal with an average of 2.87% increase in signal on the contralateral side. 

Our preliminary data provide evidence to support that increased thalamic inflammation is linked to PTN. If further confirmed, this work would provide a rationale for exploring neuroinflammation as a therapeutic target for this condition.   

Authors/Disclosures
Megan Heffernan, BS (MGH)
PRESENTER
Ms. Heffernan has nothing to disclose.
Zeynab Alshelh, PhD Dr. Alshelh has nothing to disclose.
You-Chia Chen, MD Dr. Chen has nothing to disclose.
Jack H. Schnieders, BS Mr. Schnieders has nothing to disclose.
Minhae Kim, BA Ms. Kim has nothing to disclose.
Robert Edwards, PhD Dr. Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott Williams & Wilkins.
Marco Loggia, PhD Dr. Loggia has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Association for the Study of Pain. Dr. Loggia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Hsinlin T. Cheng, MD (Massachusettes General Hospital) Dr. Cheng has nothing to disclose.